Back to Search Start Over

Sequana Medical announces safety and quality data from POSEIDON study of alfapump

Source :
PharmaBiz. June 7, 2024
Publication Year :
2024

Abstract

Sequana Medical NV, a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, announced data from its North American pivotal POSEIDON study of the alfapump [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
PharmaBiz
Publication Type :
Periodical
Accession number :
edsgcl.796759359